Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of agrochemicals and active pharmaceutical ingredients (APIs). Its structure allows for further functionalization, making it valuable in creating compounds with biological activity. Commonly employed in cross-coupling reactions such as Suzuki or Buchwald-Hartwig aminations due to the presence of bromine and cyano groups. The trifluoromethyl group enhances lipophilicity and metabolic stability in final products, which is beneficial in drug design. Also utilized in the preparation of kinase inhibitors and other targeted therapies in medicinal chemistry research.